Myriad Genetics, Inc. (MYGN) Sponsors Cancer Awareness Initiatives in Support of National Hereditary Breast and Ovarian Cancer Week
10/4/2012 10:02:54 AM
SALT LAKE CITY, Oct. 3, 2012 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that, in support of National Hereditary Breast and Ovarian Cancer (HBOC) Week and National Previvor Day, it has launched an online quiz to help people assess their risk for hereditary cancers. The Hereditary Cancer Quiz is available online at www.hereditarycancerquiz.com. In addition, the company is providing financial support toward educational and awareness initiatives to three advocacy organizations-Bright Pink, the National Ovarian Cancer Coalition (NOCC) and Living Beyond Breast Cancer (LBBC).
comments powered by